Family Offices Converge on RESI to Meet Early Stage Biotech and Medtech Startups

8 Jun

By Lucy Parkinson, Director of Research, LSN

RESI is a venue where early stage life science startups can meet with investors of every type that are a fit for their company’s technology and stage – and that includes family offices. RESI San Diego features two panels devoted to this elusive investor class – Biotech Family Offices and Medtech Family Offices. Whether you’re developing a novel therapeutic, an innovative device or an improved diagnostic solution, Family Offices can’t be overlooked as a potential source of capital and RESI will provide you with the opportunity to hear advice and insight directly from key investment decision makers from family offices.

Biotech Family Offices, moderated by Colin Widen (CEO, Boston Innovation Capital), features:

Medtech Family Offices, moderated by Michael Quigley (VP of Market Research, Life Science Nation), features:

To catch this rare opportunity to meet family office investors with a focus on early stage life science investment, register for RESI now.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: